Highly Potent Monofunctional Platinum (II) Anticancer Agents, cDACP (acriplatin) and cDPnCP (phenanthriplatin)
Non-Exclusively Licensed
Invention type: Technology
/
Case number: #14702
The present invention relates to compositions, kits, and methods for treatment of cancers. In some cases, the composition comprises a platinum compound comprising a phenanthridine ligand.
Researchers
Stephen J Lippard
/
Ga Young Park
Departments: Department of Chemistry
Technology Areas: Diagnostics: Assays / Therapeutics: Small Molecules
Impact Areas: Healthy Living
-
compositions and methods for the treatment of cancer
United States of America | Granted | 9,034,862
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.